We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brand, Generic Drug Cost Report Sought by House Committee
Brand, Generic Drug Cost Report Sought by House Committee
November 24, 2009
Allegations that drugmakers are raising prices in anticipation of healthcare legislation that may reduce pharmaceutical costs or curb growth have led several House committee leaders to request a Government Accountability Office (GAO) investigation on recent price trends.